Back
Kura Oncology Vs. Perspective Therapeutics Industry Stock Comparison
Sell
16
KURA
Kura Oncology
Last Price:
10.73
Seasonality Move:
11.8%
Sell
30
CATX
Perspective Therapeutics
Last Price:
4.38
Seasonality Move:
34.33%
Sell
16
Kura Oncology (KURA)
is a Sell
Is Kura Oncology a Buy, Sell or Hold?
- The current Kura Oncology [KURA] share price is $10.96. The Score for KURA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- KURA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $3.69. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KURA Stock Price Chart
What is Kura Oncology's stock price today?
-
The Kura Oncology share price today is $10.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KURA is experiencing slight selling pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $3.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.
KURA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.59 | Sell |
Relative Strength Index (14 RSI): | 23.01 | Sell |
Chaikin Money Flow: | -331407 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.15 - 18.65) | Sell |
Bollinger Bands (100): | (16.87 - 21.13) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.2 | Sell |
Relative Strength Index (14 RSI): | 16.48 | Sell |
Chaikin Money Flow: | -2576008 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.81 - 12.79) | Sell |
Bollinger Bands (100): | (10.03 - 14.87) | Sell |
KURA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.02 | Sell |
20-day SMA: | 16.13 | Sell |
50-day SMA: | 17.73 | Sell |
200-day SMA: | 19.89 | Sell |
8-day EMA: | 13.43 | Sell |
20-day EMA: | 15.43 | Sell |
50-day EMA: | 17.18 | Sell |
200-day EMA: | 18.22 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.86 | Sell |
20-day SMA: | 9.29 | Sell |
50-day SMA: | 11.35 | Sell |
200-day SMA: | 12.7 | Sell |
8-day EMA: | 5.68 | Sell |
20-day EMA: | 8.26 | Sell |
50-day EMA: | 10.6 | Sell |
200-day EMA: | 11.28 | Sell |
Kura Oncology Earnings Growth & KURA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.50 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
Kura Oncology Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |